An Initial Evaluation of the Carillon Mitral Contour System for Treatment of Atrial Function Mitral Regurgitation

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

September 22, 2021

Study Completion Date

December 22, 2022

Conditions
Functional Mitral RegurgitationAtrial FibrillationAtrial Functional Mitral Regurgitation
Interventions
DEVICE

Carillon Mitral Contour System

Eligible subjects will be implanted with the Carillon Device, utilizing the Carillon Mitral Contour System. The device is a permanent implant in the coronary sinus/great cardiac vein, designed to cinch the mitral annulus. The implant procedure is minimally invasive, conducted via catheter placement.

Trial Locations (2)

Unknown

Royal Prince Alfred, Sydney

European Interbalkan Medical Center, Thessaloniki

Sponsors
All Listed Sponsors
lead

Cardiac Dimensions Pty Ltd

INDUSTRY